The commission announced the investigations following concerns from advocacy groups, according to a Nov. 16 news release. The investigations will look to determine if the hospitals’ policies and practices regarding drug testing of pregnant people and newborns show discriminatory racial bias.
Although a positive toxicology test doesn’t merit a call to the State Central Register of Child Abuse and Maltreatment, some advocates say hospitals continue to use a single unconfirmed positive screen as a reason to report parents to the SCR. If the SCR accepts the report, the local child welfare agency is legally required to launch a child protection investigation.
At the time of publication, representatives from Montefiore Medical Center, Mount Sinai and NewYork-Presbyterian had not responded to Becker’s request for comment.
More articles on legal and regulatory issues:
Virginia physician convicted on 52 charges related to billing fraud scheme
Ohio hospital files antitrust suit against ProMedica
Kaiser pays $6.4M to settle false claims allegations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
